Delivery Order 75N95024D00009-75N95025F00003

Award Date 9/29/25
Potential Completion Date 9/28/28
Potential Value $45K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Torrance, CA 90505, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $26,400.00 and an ultimate completion date of March 31, 2027. It is for the provision of extended stability studies of parathyroid hormone-related protein (PTH-IA) to support...
The National Institutes of Health National Center for Advancing Translational Sciences awarded Bachem Americas, Inc. a $597,350 firm fixed price delivery order contract under the prime vendor's master indefinite-delivery/indefinite-quantity contract for Clinical Research Organization Support. The order is for Bachem Americas, Inc. to manufacture 150 grams of cGMP Parathyroid Hormone-related Protein type 1A in support of the funding agency's drug substance development and manufacture programs....
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Bachem Americas, Inc. for the custom synthesis of 20 mg peptides with >95% purity, including quality control analytical services. The contract ceiling value is $4,315.00 and the ultimate completion date is March 26, 2016. Bachem Americas, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical ingredients...
This is a $99,715.40 firm fixed-price purchase order awarded to Cisbio US, Inc., a foreign-owned for-profit company, by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services (HHS). The contract is for the provision of assay kits, cell lines, and collagen reagents to support research activities. This award was not set aside and is the latest in a series of similar purchase orders awarded to Cisbio US, Inc. to provide biomarker...
This federal contract award, HHSN271201500631P, was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $84,700 firm-fixed-price purchase order contract is for the provision of assay kits and reagents, including those used to detect biomarkers related to disease research, as well as cell lines and collagen reagents. The contract has a total small business...
This federal contract award, with the ID HHSN271201500620P, was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. government. The contract, with a ceiling value of $148,905.00, was awarded to Chembridge Corp, a for-profit organization based in San Diego, California. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, which is a purchase order with a firm fixed price. The contract does not have a...
The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...
This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency within the Department of Health and Human Services, to Biotage, LLC, a manufacturer of specialized analytical chemistry equipment. The $87,839.95 firm fixed-price purchase order was for a NCATS BIOTAGE PEPTIDE SYNTHESIZER, which will be delivered by November 21, 2015. The contract was not set aside for a specific business type. Biotage, LLC is a for-profit limited liability company that has...
This is a $36,000.00 firm fixed-price contract awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to Entrechem SL, a for-profit manufacturer located in Spain, to provide 100g each of two specialized chemical compounds, (1S,2S)-trans-N-Boc-Tetrahydro-3,4-furandiamine and (1R,2R)-trans-N-Boc-Tetrahydro-3,4-furandiamine. These compounds are needed as starting...
<p>This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Biovision Inc., a small disadvantaged business, on April 24, 2015. The contract is for the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, with a ceiling value of $95,640.25 and a completion date of July 25, 2015. The contract does not have a set-aside designation.</p>
  • 75N95024D00009
    Indefinite Delivery Contract
  • 75N95024D00009-75N95025F00003
    Delivery Order

This federal contract award is a task order from the National Institute on Drug Abuse (NIDA), a civilian agency, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturing company. The task order is for a 3-year stability study extension on a current Good Manufacturing Practice (cGMP) batch of parathyroid hormone-related protein (PTH-IA). The total ceiling value of this firm fixed-price delivery order is $45,200.00.

Bachem Americas Inc. has an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Center for Advancing Translational Sciences (NCATS) to provide Chemistry, Manufacturing, and Controls (CMC) services supporting drug development programs, including cGMP manufacturing. This task order award is not set-aside and does not involve any major subcontractors, with Bachem Americas Inc. serving as the prime contractor.

Generated 9/26/25, 9:43 AM